Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Where is the peer reviewed papers for Aristotle
View:
Post by Sockeye2 on Apr 12, 2021 1:01pm

Where is the peer reviewed papers for Aristotle

I agree that they have not given enough details about Aristotle in the form of peer reviewed papers and also why are companies like Illumina not at least looking at them.  I have been involved in science projects involving salmon and been through the peer review process. Scientists that are on that journal scrutinize your work and they will not publish your paper unless the data adds up or makes sense.  This would be a good question for Tripp at the AGM
Comment by WizzyYR0 on Apr 12, 2021 1:04pm
This post has been removed in accordance with Community Policy
Comment by capebretongirl on Apr 12, 2021 1:14pm
The worst cancer diagnosis is a late one, yet more than 40% of cancers are still found in the later stages.  Our next-generation blood test (Aristotle™) is a panel for the early detection of 10 cancers from a single sample of blood. Aristotle was recently selected for online publication at the 2020 annual meeting of the American Society of Clinical Oncology (ASCO).
Comment by gojotv! on Apr 12, 2021 1:24pm
Hahaha, capebretongirl caught our resident troll-of-a-million-aliases in a lie... AGAIN! It's a full-time job, lol!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities